INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 169 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $377,000 | -78.3% | 10,119 | -76.3% | 0.05% | -79.8% |
Q2 2021 | $1,739,000 | +311.1% | 42,611 | +242.0% | 0.26% | +242.7% |
Q1 2021 | $423,000 | -50.0% | 12,459 | -53.2% | 0.08% | -56.9% |
Q4 2020 | $846,000 | +18.8% | 26,606 | -4.1% | 0.17% | -4.4% |
Q3 2020 | $712,000 | +33.8% | 27,737 | +33.9% | 0.18% | +2.2% |
Q2 2020 | $532,000 | +9.7% | 20,714 | -34.4% | 0.18% | -12.3% |
Q1 2020 | $485,000 | -48.6% | 31,554 | -56.6% | 0.20% | -8.6% |
Q2 2019 | $944,000 | +30.9% | 72,758 | +14.9% | 0.22% | +14.4% |
Q4 2018 | $721,000 | +79.4% | 63,304 | +231.6% | 0.19% | +115.6% |
Q1 2018 | $402,000 | +64.8% | 19,088 | +13.4% | 0.09% | +66.7% |
Q4 2017 | $244,000 | -16.2% | 16,826 | -8.7% | 0.05% | -16.9% |
Q3 2017 | $291,000 | – | 18,429 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |